These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 34652548)
1. SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study. Baker JL; Haji F; Kusske AM; Fischer CP; Hoyt AC; Thompson CK; Lee MK; Attai D; DiNome ML Breast Cancer Res Treat; 2022 Jan; 191(1):107-114. PubMed ID: 34652548 [TBL] [Abstract][Full Text] [Related]
2. Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection. Weinfurtner RJ; Leon A; Calvert A; Lee MC Clin Imaging; 2022 Oct; 90():19-25. PubMed ID: 35908456 [TBL] [Abstract][Full Text] [Related]
3. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers. Laws A; Dillon K; Kelly BN; Kantor O; Hughes KS; Gadd MA; Smith BL; Lamb LR; Specht M Ann Surg Oncol; 2020 Nov; 27(12):4819-4827. PubMed ID: 32740737 [TBL] [Abstract][Full Text] [Related]
4. Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy. Cabıoğlu N; Karanlık H; Yılmaz R; Emiroğlu S; Tükenmez M; Bademler S; Şimşek DH; Kantarcı TR; Yirgin İK; Bayram A; Dursun M World J Surg Oncol; 2024 Jul; 22(1):178. PubMed ID: 38971793 [TBL] [Abstract][Full Text] [Related]
5. Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer. Mariscal Martínez A; Vives Roselló I; Salazar Gómez A; Catanese A; Pérez Molina M; Solà Suarez M; Pascual Miguel I; Blay Aulina L; Ríos Gozálvez C; Julián Ibáñez JF; Rodríguez Martínez P; Martínez Román S; Margelí Vila M; Luna Tomás MA Surg Oncol; 2021 Mar; 36():28-33. PubMed ID: 33285433 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer. Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Targeted Axillary Dissection With Radar Reflector Localization Before Neoadjuvant Chemotherapy. Coogan AC; Lunt LG; O'Donoghue C; Keshwani SS; Madrigrano A J Surg Res; 2024 Mar; 295():597-602. PubMed ID: 38096773 [TBL] [Abstract][Full Text] [Related]
8. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy? Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791 [TBL] [Abstract][Full Text] [Related]
9. Early reflector localization improves the accuracy of localization and excision of a previously positive axillary lymph node following neoadjuvant chemotherapy in patients with breast cancer. Balija TM; Braz D; Hyman S; Montgomery LL Breast Cancer Res Treat; 2021 Aug; 189(1):121-130. PubMed ID: 34159474 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of Axillary Lymph Node Localization and Excision Using Radar Reflector Localization. Sun J; Henry DA; Carr MJ; Yazdankhahkenary A; Laronga C; Lee MC; Hoover SJ; Sun W; Czerniecki BJ; Khakpour N; Kiluk JV Clin Breast Cancer; 2021 Jun; 21(3):e189-e193. PubMed ID: 32893094 [TBL] [Abstract][Full Text] [Related]
11. Concomitant Use of Biopsy Clips and Wire Localization in Invasive Breast Cancer is Associated With Successful Clip Retrieval. Chen JH; Canner JK; Myers K; Camp M Clin Breast Cancer; 2023 Apr; 23(3):e163-e172. PubMed ID: 36646538 [TBL] [Abstract][Full Text] [Related]
12. Radar reflector guided axillary surgery in node positive breast cancer patients. Feinberg JA; Axelrod D; Guth A; Maldonado L; Darvishian F; Pourkey N; Goodgal J; Schnabel F Expert Rev Med Devices; 2022 Oct; 19(10):791-795. PubMed ID: 36345879 [TBL] [Abstract][Full Text] [Related]
13. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528 [TBL] [Abstract][Full Text] [Related]
14. Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study. Wu SY; Li JW; Wang YJ; Jin KR; Yang BL; Li JJ; Yu XL; Mo M; Hu N; Shao ZM; Liu GY Int J Surg; 2023 Jul; 109(7):1863-1870. PubMed ID: 37132193 [TBL] [Abstract][Full Text] [Related]
15. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes. Plecha D; Bai S; Patterson H; Thompson C; Shenk R Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365 [TBL] [Abstract][Full Text] [Related]
16. Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study. Yang X; Li Y; Ren XT; Fan L; Hua B World J Surg Oncol; 2023 Jul; 21(1):214. PubMed ID: 37480099 [TBL] [Abstract][Full Text] [Related]
17. Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial. Chen X; Lu Z; Wang C; Lyu M; Qiao J; Sun X; Li L; Zhang C; Liu Z Chin Med J (Engl); 2024 Jun; 137(12):1421-1430. PubMed ID: 38557731 [TBL] [Abstract][Full Text] [Related]
18. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results. Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211 [TBL] [Abstract][Full Text] [Related]
19. Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy. Balasubramanian R; Morgan C; Shaari E; Kovacs T; Pinder SE; Hamed H; Sever AR; Kothari A Eur J Surg Oncol; 2020 Jun; 46(6):1028-1033. PubMed ID: 31879050 [TBL] [Abstract][Full Text] [Related]
20. When the clipped node goes missing, CT guided SAVI SCOUT placement: A novel approach for localizing soft tissue targets. Lifrieri A; Fuzesi S; Desperito E; Taback B Clin Imaging; 2022 May; 85():115-117. PubMed ID: 35278870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]